Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-18T11:19:40.497Z Has data issue: false hasContentIssue false
  • English
  • Français

20 The Need for Speed: Adjunctive Triple Chronotherapy in the Accelerated Treatment of Acute Depression and Suicidality in the Adolescent Population

Published online by Cambridge University Press:  12 March 2019

Diane Hurd ,
Eric Arzubi ,
Mariela Rojas Herrera ,
Nicholas Coombs  and
Jeannine Brant
Diane Hurd
Affiliation:
Psychiatric Nurse Practitioner, Behavioral Health Center, Billings Clinic, Billings, MT
Eric Arzubi
Affiliation:
Child Adolescent Psychiatrist, Chair of Psychiatry, Billings Clinic, Billings, MT
Mariela Rojas Herrera
Affiliation:
Child Adolescent Psychiatrist, Director of the Psychiatric Youth Treatment Unit, Billings Clinic, Billings, MT
Nicholas Coombs
Affiliation:
Data Analyst, Collaborative Science & Innovation, Billings Clinic, Billings, MT
Jeannine Brant
Affiliation:
Nurse Scientist, Collaborative Science and Innovation, Billings Clinic, BillingsMT
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective

This pilot study aims to explore the feasibility and proof of concept of triple chronotherapy (TCT) as a non-pharmacological, adjunctive intervention in the treatment of acute depression and suicidality in the adolescent population.

Method

Thirty-one adolescents with moderate to severe depression were included in the study. Each participant underwent a 4-day intervention (TCT) which consisted of one night of sleep deprivation followed by three days of sleep phase advancement and daily bright light therapy. Primary outcomes were feasibility and depression, as measured by Hamilton Depression Scale-17 (HAMD-17) scores. Secondary outcomes included severity of illness, anxiety, self-harm, insomnia, and suicidality.

Results

Twenty-nine (94%) adolescents completed the TCT protocol. Twenty-six (84%) of the 31 enrolled patients experienced a reduction in depressive symptoms of at least 50% from baseline; 24 (77%) achieved remission, defined as a HAMD-17 score less than 8. Secondary outcomes showed significant improvement following the 4-day TCT intervention; improvement was sustained through the 7–10 day and 1-month follow-up periods.

Conclusion

This pilot study determined TCT to be a feasible, safe, accelerated, and promising adjunctive treatment for acute depression in the adolescent population. This study has been submitted for publication and is currently under review.

Type
Abstracts
Information
CNS Spectrums , Volume 24 , Issue 1 , February 2019 , pp. 183 - 184
Copyright
© Cambridge University Press 2019